Overview
IonQ Q2 2025 revenue beats analyst expectations
Net loss for Q2 widens
Company announces $1.075 bln acquisition of Oxford Ionics to enhance quantum capabilities
Outlook
IonQ expects full-year 2025 revenue between $82 mln and $100 mln
Company sees third-quarter revenue between $25 mln and $29 mln
IonQ aims for 800 logical qubits by 2027
Company plans 80,000 logical qubits by 2030
Result Drivers
ACQUISITIONS - Completed acquisitions of Lightsynq and Capella, enhancing quantum computing and networking capabilities
PROPOSED ACQUISITION - Announced $1.075 bln acquisition of Oxford Ionics to advance quantum computing roadmap
DRUG DEVELOPMENT - Achieved 20x speed-up in quantum-accelerated drug development with AstraZeneca, AWS, and NVIDIA
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$20.69 mln
$17.20 mln (6 Analysts)
Q2 EPS
-$0.7
Q2 Net Income
-$177.53 mln
Q2 Operating Income
-$160.59 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the it services & consulting peer group is "buy"
Wall Street's median 12-month price target for IONQ Inc is $50.00, about 16% above its August 5 closing price of $42.02
Press Release: ID:nBw8VtNk9a
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)